These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 39394650)
1. Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis. Wang J; Wu C; Deng Z Expert Opin Drug Saf; 2024 Oct; ():1-7. PubMed ID: 39394650 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis. Wang J; Wang S; Wu C; Deng Z Infection; 2024 Jun; 52(3):891-899. PubMed ID: 37996645 [TBL] [Abstract][Full Text] [Related]
3. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report. Xie W; Wang Q; Gao Y; Pan CQ BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094 [TBL] [Abstract][Full Text] [Related]
4. Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma. Nano O; Ivanov S; Kapoor T J Med Cases; 2023 May; 14(5):162-168. PubMed ID: 37303969 [TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study. Deng Z; Wang S; Wu C Front Pharmacol; 2023; 14():1197470. PubMed ID: 37849732 [No Abstract] [Full Text] [Related]
6. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review. Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210 [TBL] [Abstract][Full Text] [Related]
8. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen. Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781 [TBL] [Abstract][Full Text] [Related]
9. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report. Takaki Y; Murahashi M; Honda K; Hirai K Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021. Jiang T; Su H; Xu J; Li C; Zhang N; Li Y; Wu Y; Ni R; Ming Y; Li Z; Li L; Liu Y Ther Adv Drug Saf; 2024; 15():20420986231224227. PubMed ID: 38293566 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of drug-induced vanishing bile duct syndrome]. Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557 [TBL] [Abstract][Full Text] [Related]
12. Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report. Nwaesei AS; Moye-Dickerson PM; Dretler RH J Pharm Pract; 2021 Apr; 34(2):319-324. PubMed ID: 31451051 [TBL] [Abstract][Full Text] [Related]
13. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis. Mizuno F; Imai N; Yasuda K; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M; Kawashima H Intern Med; 2024 Jan; 63(1):57-61. PubMed ID: 37164665 [TBL] [Abstract][Full Text] [Related]
14. A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS). Zhou J; Zhang J; Wang Q; Peng M; Qian Y; Wu F; Rao Q; DanZhen L; Yang Y; Wang S; Liu M Ther Adv Drug Saf; 2024; 15():20420986241284105. PubMed ID: 39381060 [TBL] [Abstract][Full Text] [Related]
15. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome. Yu P; Zhou Y; Li X J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive biomarkers for identification of vanishing bile duct syndrome among children with acute cholestatic hepatitis. Wang NL; Chen L; Lin J; Lu Y; Fang WY; Xie XB; Wang JS Transl Pediatr; 2023 Oct; 12(10):1782-1790. PubMed ID: 37969129 [TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson Syndrome Following Non-steroidal Anti-inflammatory Drugs: A Real-World Analysis of Post-marketing Surveillance Data. Shao QH; Yin XD; Zeng N; Zhou ZX; Mao XY; Zhu Y; Zhao B; Li ZL Front Pediatr; 2022; 10():896867. PubMed ID: 35601418 [TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases. Oppenheimer AP; Koh C; McLaughlin M; Williamson JC; Norton TD; Laudadio J; Heller T; Kleiner DE; High KP; Morse CG World J Gastroenterol; 2013 Jan; 19(1):115-21. PubMed ID: 23326172 [TBL] [Abstract][Full Text] [Related]
19. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission. Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983 [TBL] [Abstract][Full Text] [Related]
20. Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma. Gaudel P; Brown P; Byrd K Cureus; 2022 Jul; 14(7):e26842. PubMed ID: 35974868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]